BioLineRx Ltd. is on the Cruelty Free Investing use of animals list because they conduct Pre-clinical studies of their drugs on animals to assess a product’s safety profile.
In the following Press Releases company announced the findings of pre-clinical studies of their drugs.
- It has been shown that BL-5040 can block inflammation in animal models without discernible side-effects. Read the full article.
- Pre-clinical studies in various animal models have demonstrated BL-1040’s safety and efficacy in preventing thinning of the cardiac wall and stabilizing anatomical and clinical parameters. Read the full article.
BioLineRx Ltd. is a clinical-stage biopharmaceutical company, which includes indentifying, in-licensing, and developing therapeutic candidates. Its in-licenses novel compounds, primarily from academic institutions and biotech companies based in Israel, and develops them through pre-clinical and clinical stages, and then partners with pharmaceutical companies clinical development and commercialization. The company was founded in April 2003 and is headquartered in Modi’in, Israel. [Source: MarketWatch]